Table of Contents Table of Contents
Previous Page  867 / 916 Next Page
Information
Show Menu
Previous Page 867 / 916 Next Page
Page Background

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S847–S910

S863

Objective

To determine the impact of HBV/HCV co-infection on

the long-term survival of schizophrenic patients with co-occurring

substance use disorders.

Methods

Charts of 223 subjects admitted from January 1, 2002 to

May 31, 2006 were assessed. The Kaplan–Meier survival analysis

was used to estimate the cumulative survival rates. The associ-

ation between HBV/HCV and mortality was estimated using the

Cox proportional-hazard regression models, with adjustments for

potential confounders. The main outcome was all-cause mortality.

Median observation time was 10.3 years.

Results

Total all-cause 11 year, unadjusted mortality was 18.0%

in population with no viral hepatitis (VH) infection (

n

= 185;

83.0%), 66.7% in population with HBV monoinfection (

n

= 3;

1.3%), 50.0% in population with HCV monoinfection (

n

= 28;

12.6%), and 64.3% in population with HBV/HCV co-infection

(

n

= 7; 3.1%),

P

< 0.00001. In Cox regression, the adjusted haz-

ard ratio was 4.22 (95% CI: 1.00–18.63;

P

< 0.05) for the

HBV, 4.24 (95% CI: 2.13–8.47;

P

< 0.00001) for the HCV, 6.18

(95% CI: 2.01–19.01;

P

< 0.0015) for the HBV/HCV, all vs. no

VH-infection.

Conclusions

The high mortality of schizophrenic dual disorders

patients with HBV/HCV necessitates new approaches to secondary

and tertiary prevention to reduce the burden of chronic liver dis-

ease and to improve survival. The strong adverse effect of HBV/HCV

on survival should encourage clinical trials including schizophrenic

dual disorders patients on whether patients benefit from treat-

ment choices. It is essential that adequate resources and strategies

are targeted to the schizophrenic dual disorders patients with

HBV/HCV.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1724

EV1395

Increased intake of monosaccharides

and disaccharides in opioid-addicts

E.J. Gorzela ´nczyk

1 ,

, A . S

zponar

2 , P. W

alecki

2

1

Nicolaus Copernicus University, Medical College, Department of

Theoretical Biomedical Sciences and Medical Informatics, Bydgoszcz,

Poland

2

Jagiellonian University Medical College, Faculty of Medicine,

Krakow, Poland

Corresponding author.

Introduction

Persons dependent on opioids often characterized

by the coexistence of a whole range of dysfunctional behaviors,

which may also lead to eating disorders.

Objectives

Impulsive and risky behavior, conducive to the for-

mation of polysubstance dependence, including food addiction,

which manifests itself in the uncontrollable craving substances,

that are quickly metabolized and turned into sugar in the

bloodstream.

Aims

Aim of the study was to assess the nutritional status

and carbohydrates consumption in opioid-dependent individuals

treated with methadone substitution therapy.

Methods

Fourteen opioid addicts during methadone mainte-

nance treatment were examined. Eighteen healthy individuals

matched for age and gender were included to the control group.

The 24 hour hour diet recalls interview was used. After the dietary

recall, a special questionnaire was administered to ascertain fre-

quency of refined carbohydrates consumptions during the past

30 days.

Results

It was found the nutritional deficiencies in the diet and

poor nutritional status in opioid-addicts compared to healthy

ones. Opioid-dependent individuals significantly more often snack

between meals. It was found increased consumption monosaccha-

rides and disaccharides in foods and beverages in opioid-addicts

compared to healthy ones (

P

< 0.05).

Conclusions

Investigation of dietary behaviors may facilitate

understanding of dynamics of addiction, so that we can use more

effective methods of treatment.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1725

EV1396

The cat and the mouse game: Is there

a shift towards more dangerous

substances in the cathinone illicit

market?

M. Grifell

1 ,

, L. Galindo

1

, M. Ventura

2

, E. Ribera

1

, P. Quintana

2

,

A. Palma

1

, X. Carbón

2

, L. Gonzalez

1

, L. San-Emeterio

1

,

C. Diez-Aja

1

, F. Caudevilla

2

, M. Torrens

1

1

Parc de Salut Mar, Institut de Neuropsiquiatria i Addiccions,

Barcelona, Spain

2

ABD, Energy Control, Barcelona, Spain

Corresponding author.

Introduction

After mephedrone’s ban in March 2010 new

cathinones proliferated widely, even a new branch of atypi-

cal derivatives was launched into the market, represented by

MDPV. The cardiovascular and central nervous system toxicity

draws attention to this new family of cathinones, also known as

pyrovalerones. MDPVwas scheduled in 2011, leading to the appari-

tion of Alpha-PVP from which there is little information.

Objectives

The aim of the present study is to describe the evolu-

tion of different cathinones in the samples delivered for analysis to

the harm reduction NGO energy control fromMarch 2009 to March

2016 in Spain.

Methods

Energy control is a Spanish harm reduction NGO that

offers to drug users the possibility of analyzing the substances

they intend to consume. From March 2009 to March 2016 a

total of 24,528 samples were analyzed by the NGO from which

760 contained cathinones. Substance analysis was done by gas

chromatography–mass spectrometry.

Results

From 2009 to 2016, cathinones represented a 2.82% from

all analyzed samples. From March 2009 to March 2010, only 5 dif-

ferent cathinones were detected, in this same period methylone

(

n

= 16; 37.20%) and mephedrone (

n

= 17; 39.53%) represented 76%

of analyzed cathinones (

n

= 43). From March 2015 to March 2016,

132 cathinones were detected: methylone and mephedrone rep-

resented only 19.69%, giving prominence to clephedrone (

n

= 25;

18.93%) and Alpha-PVP (

n

= 24; 18.18%).

Conclusions

The evolution of synthetic cathinones detected by

energy control is consistent with the evolution described in the

literature. From 2009 to 2016, the cathinones detected diversify

and new substances with higher toxicity potential appear.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1726

EV1397

Is cloninger type 1 and type 2

alcoholism differ in terms of emotion

regulation?

D. Gulec Oyekcin

, A. G

urgen

Canakkale Onsekiz Mart University Medical Faculty, Psychiatry,

Canakkale, Turkey

Corresponding author.

Introduction

Emotional disturbances are a central characteristic

of many mental disorders, including alcohol addiction.

Objectives

In this study we aimed to investigate the emotion

disregulation among alcohol use disorders and to compare the

emotion regulation difficulties with type 1 and type 2 alcoholism.